Lenalidomide (Revlimid®) maintenance post autologous stem cell transplant We are delighted to announce that as of 1 April 2020 the pharmaceutical benefits scheme (PBS) have listed lenalidomide (Revlim...
Archive for month: April, 2020
Copyright © 2010 - 2022 Myeloma Foundation of Australia Inc . All rights reserved. Hosted by Zenhosting